A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Evaluating the Anti-Tumor Efficacy of a Bacterial Immunomodulatory Protein in a Murine Model

693 views

⸱

July 8th, 2025

In This Article

Abstract

Source: Codolo, G. et al. Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model. J. Vis. Exp. (2015)

This video demonstrates a technique to assess the anti-tumor activity of Helicobacter pylori neutrophil-activating protein, or HP-NAP, in a mouse bladder cancer model. HP-NAP interacts with tumor-cell neutrophils to produce pro-inflammatory cytokines, inducing the differentiation of naïve T cells into type 1 T helper (Th1) and type 1 cytotoxic (Tc1) T cell phenotypes. The Th1 and Tc1 cells secrete interferon-gamma, inhibiting tumor angiogenesis and promoting cytotoxic T cell-mediated tumor destruction, reducing tumor volume.

Protocol

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board.

1. Animals

  1. Grow C57BL6/J female mice to 8 weeks of age in individually ventilated cages with microisolation filters.
    NOTE: Females are preferred because the anatomic conformation of their external urogenital apparatus renders the catheterization easier than in males.

2. Cell Culture

  1. Maintain the mouse urothelial carcinoma cell line MB49 in RPMI 1640 medium supplemented with 10% heat-....

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
C57BL/6J female miceHarlan Italy (Udine, Italy)
MB49 CellsObtained from Prof. O'Donnel, University of Iowa Carver College of Medicine, Iowa, USA
RPMISigma-Aldrich (St. Louis, Missouri, USA)R8758
FBSSigma-AldrichF7524
PBSSigma-AldrichD140810X, to be diluted in apyrogenic water
FlaskBecton Dickinson (Franklin Lakes, New Jersey, USA)353135
Syringe 1mlBecton Dickinson301358
TrypsinLife Technologies (Waltham, Massachusetts, USA)
GentamycinLife Technologies15710-049
XilorBio 98 s.r.l. (Milano, Italy)2% Xylazin
ZoletilVirbac (Carros, France)3.59713E+115% Zolazepam + 5% Tiletamine
24G CatheterTerumo (Rome, Italy)SR+DM2419PX
HClCarlo Erba Reagents (Milano, Italy)403871Liquid
NaOHJT Baker (Center Valley, Pennsylvania, USA)10095011Powder

Explore More Articles

HP-NAP ProteinBladder Cancer ModelTh1 T CellsTc1 T CellsInterferon GammaTumor AngiogenesisCytotoxic T CellsToll-like Receptors